Hikal signs long term supply pact with leading global Biopharma Company

02 Jul 2013 Evaluate

Hikal, the preferred long-term outsourcing partner for leading global life sciences companies, has signed a long term pharmaceutical supply contract with a global biopharmaceutical company. The agreement covers the production and supply from the company’s pharmaceutical division. The customer is a leading innovator company which serves markets globally for human health treatments.

Hikal is a reliable partner to companies in the Pharmaceuticals, Biotech, Agrochemicals and Specialty Chemicals industries. They provide world-class Active Ingredients, Intermediates and R&D services and solutions in a safe, secure and confidential manner.

Hikal Share Price

208.00 -4.20 (-1.98%)
20-Jan-2026 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.00
Dr. Reddys Lab 1166.90
Cipla 1381.00
Zydus Lifesciences 872.95
Lupin 2160.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×